Daily Sundial

Bydureon Weight Loss Injection Review – Bydureon Bcise Exenatide Extended Release Alternatives Over the Counter

Below are 3 natural substitutes to Bydureon that can reduce body weight and control blood sugar levels. For best results it is possible to use in a stack – this means combining 2 or more products ...
Healio

Once-weekly exenatide improved glucose control, weight loss in DURATION studies

Please provide your email address to receive an email when new articles are posted on . ORLANDO — A once-weekly injection of exenatide may be an important therapeutic option for patients with type 2 ...
Medscape

Exenatide Approved for Type 2 Diabetes: An Expert Interview With John B. Buse, MD, PhD

May 4, 2005 (updated May 5, 2005) — Editor's Note: On April 29, Amylin Pharmaceuticals, Inc., and Eli Lilly and Co. announced that the U.S. Food and Drug Administration (FDA) had approved exenatide ...
FiercePharma

Exenatide Once Monthly Showed Positive Results in Phase 2 Study

The 121-patient, phase 2 study assessed the efficacy, safety and tolerability of three different doses of exenatide once monthly. It also assessed exenatide once weekly (exenatide extended-release for ...
FierceBiotech

Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events

SAN DIEGO, INDIANAPOLIS, and CAMBRIDGE, Mass., March 26 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc., (NASDAQ: AMLN) , Eli Lilly and Company (NYSE: LLY) and ...
FierceBiotech

PRESS RELEASE: Once-Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study

SAN DIEGO & INDIANAPOLIS & CAMBRIDGE, Mass., Oct 31, 2007 (BUSINESS WIRE) -- Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (NASDAQ: ALKS) today ...
Medscape

Once-Weekly Exenatide Okayed by FDA for T2DM After Long Look

January 27, 2012 — The US Food and Drug Administration (FDA) today approved a once-weekly extended-release formulation of exenatide injection (Bydureon, Amylin Pharmaceuticals) as an adjunct to diet ...
Healio

Exenatide reduced HF risk by half in type 2 diabetes

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Data from a retrospective analysis have ...
FiercePharma

U.S. FDA Approves Bydureon® Pen (exenatide extended-release for injectable suspension) for Once-Weekly Treatment of Adults with Type 2 Diabetes

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca (NYSE:AZN) today announced that the U.S. Food and Drug Administration (FDA) has approved the Bydureon® Pen (exenatide extended-release for injectable ...
Nature

Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures

Exenatide (exendin-4) is an incretin mimetic currently marketed as an antidiabetic agent for patients with type 2 diabetes. In preclinical models, a reduction in body weight has also been shown in low ...